The DOI matches its Crossref record.
Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.
Abstract
The mechanisms of bee venom immunotherapy (VIT) are largely unknown. The aim of this study was to follow the changes of T cell cytokine secretion during the course of VIT. Ten bee venom-allergic patients with a history of severe systemic reactions, positive skin tests, and bee venom (BV)-specific serum IgE Abs were treated as follows: on the first day, a cumulative dose of 111 micrograms, starting with 0.1 microgram, was administered s.c. under intensive care conditions. Further injections of 100 micrograms BV were given on day 7, day 21, and thereafter at intervals of 4 wk. Blood samples were obtained just before the initiation of VIT, after the last injection on the same day, and before the subsequent BV injections on days 7, 21, and 50 of VIT. Peripheral blood mononuclear cells (PBMC) were stimulated with phospholipase A (PLA), the major BV allergen, or with a control Ag tetanus toxoid (TT). Cytokine secretion was measured 24 h after restimulation of the cultures with solid-phase bound OKT3 F(ab')2 mAbs after 7 days of culture. In PLA-stimulated cultures, VIT resulted in decreased IL-4 and IL-5 and increased IFN-gamma secretion. In TT-stimulated cultures, we observed similar levels of cytokines before and during VIT. We conclude that ultra-rush VIT changes allergen-specific T cell reactivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
Role of interleukin 10 in specific immunotherapy.
Akdis, C. A., Blesken, T., Akdis, M., Wüthrich, B., & Blaser, K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2250 · Cited by 973
Jutel, M., Akdis, M., Budak, F., Aebischer‐Casaulta, C., Wrzyszcz, M., Blaser, K., & Akdis, C. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200322919 · Cited by 915
Self-citationImmunological mechanisms of allergen-specific immunotherapy
Larché, M., Akdis, C. A., & Valenta, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1934 · Cited by 849
Mechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
Bousquet, J., Lockey, R., Malling, H. J., Alvarez-Cuesta, E., Canonica, G. W., Chapman, M. D., Creticos, P. J., Dayer, J. M., Durham, S. R., Demoly, P., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63136-5 · Cited by 736
Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma
Hawrylowicz, C. M., & O'Garra, A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1589 · Cited by 683
Hansen, G., Berry, G., DeKruyff, R. H., & Umetsu, D. T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5155 · Cited by 629
Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A. R., Malolepszy, J., Zak-Nejmark, T., Koga, R., Kobayashi, T., Blaser, K., et al. (2001) · Nature · doi:10.1038/35096564 · Cited by 587
Self-citationAkdis, M., & Akdis, C. A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1088 · Cited by 565
Grass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity
Nouri-Aria, K. T., Wachholz, P. A., Francis, J. N., Jacobson, M. R., Walker, S. M., Wilcock, L. K., Staple, S. Q., Aalberse, R. C., Till, S. J., & Durham, S. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3252 · Cited by 564
Pajno, G. B., Barberio, G., De Luca, F., Morabito, L., & Parmiani, S. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01161.x · Cited by 546
Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy
Francis, J. N., Till, S. J., & Durham, S. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1570 · Cited by 526
Sublingual immunotherapy for allergic rhinitis
Wilson, D., Torres-Lima, M., & Durham, S. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002893 · Cited by 460
Müller, U., Akdis, C. A., Fricker, M., Akdis, M., Blesken, T., Bettens, F., & Blaser, K. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70402-6 · Cited by 456
Self-citationThe role of lymphocytes in allergic disease
Romagnani, S. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.104575 · Cited by 446
Steinke, J. W., & Borish, L. (2001) · Respiratory Research · doi:10.1186/rr40 · Cited by 444
Till, S. J., Francis, J. N., Nouri-Aria, K., & Durham, S. R. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.024 · Cited by 434
Bohle, B., Kinaciyan, T., Gerstmayr, M., Radakovics, A., Jahn-Schmid, B., & Ebner, C. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.013 · Cited by 423
Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice
Bonifazi, F., Jutel, M., Biló, B. M., Birnbaum, J., Muller, U., & the EAACI Interest Group on Insect Venom Hypersensitivity (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00960.x · Cited by 420
Self-citationAllergen immunotherapy: past, present and future
Durham, S. R., & Shamji, M. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00786-1 · Cited by 413
Tighe, H., Takabayashi, K., Schwartz, D., Van Nest, G., Tuck, S., Eiden, J. J., Kagey-Sobotka, A., Creticos, P. S., Lichtenstein, L. M., Spiegelberg, H. L., et al. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107927 · Cited by 385
van Neerven, R. J. J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J., & Ipsen, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2944 · Cited by 384
Mechanisms of interleukin‐10‐mediated immune suppression
Akdis, C. A., & Blaser, K. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01235.x · Cited by 382
Immunologic changes associated with allergen immunotherapy
Durham, S. R., & Till, S. J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70079-x · Cited by 338
Interleukin-4 and lnterleukin-13: Their Similarities and Discrepancies
Chomarat, P., & Banchereau, J. (1998) · International Reviews of Immunology · doi:10.3109/08830189809084486 · Cited by 331
EBNER, C., SIEMANN, U., BOHLE, B., WILLHEIM, M., WIEDERMANN, U., SCHENK, S., KLOTZ, F., EBNER, H., KRAFT, D., & SCHEINER, O. (1997) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1997.tb01252.x · Cited by 329
The future of antigen-specific immunotherapy of allergy
Valenta, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri824 · Cited by 314
Robinson, D. S., Larché, M., & Durham, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423595 · Cited by 313
Akdis, C. A., Akdis, M., Blesken, T., Wymann, D., Alkan, S. S., Müller, U., & Blaser, K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118963 · Cited by 312
Self-citationInhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy
Wachholz, P. A., Kristensen Soni, N., Till, S. J., & Durham, S. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)02022-0 · Cited by 299
Risk assessment in anaphylaxis: Current and future approaches
Simons, F. E. R., Frew, A. J., Ansotegui, I. J., Bochner, B. S., Golden, D. B. K., Finkelman, F. D., Leung, D. Y. M., Lotvall, J., Marone, G., Metcalfe, D. D., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.05.001 · Cited by 289
Self-citationImmunological mechanisms of allergen-specific immunotherapy
Jutel, M., & Akdis, C. A. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02589.x · Cited by 279
Self-citationAllergic Rhinitis and its Impact on Asthma update: Allergen immunotherapy
Passalacqua, G., & Durham, S. R. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.045 · Cited by 277
Ferreira, F., Ebner, C., Kramer, B., Casari, G., Briza, P., Kungl, A. J., Grimm, R., Jahn‐schmid, B., Breiteneder, H., Kraft, D., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.2.231 · Cited by 271
Hansen, G., McIntire, J. J., Yeung, V. P., Berry, G., Thorbecke, G. J., Chen, L., DeKruyff, R. H., & Umetsu, D. T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7589 · Cited by 269
Pilette, C., Nouri-Aria, K. T., Jacobson, M. R., Wilcock, L. K., Detry, B., Walker, S. M., Francis, J. N., & Durham, S. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4658 · Cited by 256
T Helper 1 Cells and Interferon γ Regulate Allergic Airway Inflammation and Mucus Production
Cohn, L., Homer, R. J., Niu, N., & Bottomly, K. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1309 · Cited by 255
Bee venom allergy in beekeepers and their family members
Müller, U. R. (2005) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/01.all.0000173783.42906.95 · Cited by 109
Self-citationmRNA vaccination as a safe approach for specific protection from type I allergy
Weiss, R., Scheiblhofer, S., Roesler, E., Weinberger, E., & Thalhamer, J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.168 · Cited by 42
Metadata
- Authors
- Jutel, M., Pichler, W. J., Skrbic, D., Urwyler, A., Dahinden, C., & Müller, U. R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-04
- Volume
- 154
- Issue
- 8
- Pages
- 4187-4194
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1921048215
- Cited by
- 522
- References
- 0
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.